Literature DB >> 22008701

In vitro and in vivo activity of frenolicin B against Plasmodium falciparum and P berghei.

Jay T Fitzgerald1, Philipp P Henrich, Connor O'Brien, Michael Krause, Eric H Ekland, Corinna Mattheis, Juliana M Sá, David Fidock, Chaitan Khosla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22008701      PMCID： PMC5568418          DOI： 10.1038/ja.2011.94

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  8 in total

1.  Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches.

Authors:  Eric H Ekland; Jessica Schneider; David A Fidock
Journal:  FASEB J       Date:  2011-07-11       Impact factor: 5.191

2.  Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.

Authors:  Juliana Martha Sá; Olivia Twu; Karen Hayton; Sahily Reyes; Michael P Fay; Pascal Ringwald; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

3.  Anticoccidial activity of frenolicin B and its derivatives.

Authors:  S Omura; K Tsuzuki; Y Iwai; M Kishi; S Watanabe; H Shimizu
Journal:  J Antibiot (Tokyo)       Date:  1985-10       Impact factor: 2.649

4.  Administration of the oral antibiotic frenolicin-B selectively alters copper nutriture in male rats.

Authors:  D C Kossor; S Han; F W Kemp; R W Slauter; D Serota; D Rajaskarian; N Milner; A Davidovich; J D Bogden
Journal:  J Nutr       Date:  2001-12       Impact factor: 4.798

5.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  Carbocyclic frenolicin analogues: novel anticoccidial agents.

Authors:  R E Armer; C J Dutton; B R Fenner; S D Greenwood; K T Hall; A J Rudge
Journal:  Bioorg Med Chem Lett       Date:  1998-01-20       Impact factor: 2.823

7.  Production of deoxyfrenolicin and a new antibiotic, frenolicin B by Streptomyces roseofulvus strain AM-3867.

Authors:  Y Iwai; A Kora; Y Takahashi; T Hayashi; J Awaya; R Masuma; R Oiwa; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1978-10       Impact factor: 2.649

8.  Engineered biosynthesis of the antiparasitic agent frenolicin B and rationally designed analogs in a heterologous host.

Authors:  Jay T Fitzgerald; Christian P Ridley; Chaitan Khosla
Journal:  J Antibiot (Tokyo)       Date:  2011-09-21       Impact factor: 2.649
  8 in total
  4 in total

1.  A diastereoselective oxa-Pictet-Spengler-based strategy for (+)-frenolicin B and epi-(+)-frenolicin B synthesis.

Authors:  Yinan Zhang; Xiachang Wang; Manjula Sunkara; Qing Ye; Larissa V Ponomereva; Qing-Bai She; Andrew J Morris; Jon S Thorson
Journal:  Org Lett       Date:  2013-10-23       Impact factor: 6.005

2.  Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects.

Authors:  Qing Ye; Yinan Zhang; Yanan Cao; Xiachang Wang; Yubin Guo; Jing Chen; Jamie Horn; Larissa V Ponomareva; Luksana Chaiswing; Khaled A Shaaban; Qiou Wei; Bradley D Anderson; Daret K St Clair; Haining Zhu; Markos Leggas; Jon S Thorson; Qing-Bai She
Journal:  Cell Chem Biol       Date:  2019-01-17       Impact factor: 8.116

3.  Frenolicins C-G, pyranonaphthoquinones from Streptomyces sp. RM-4-15.

Authors:  Xiachang Wang; Khaled A Shaaban; Sherif I Elshahawi; Larissa V Ponomareva; Manjula Sunkara; Yinan Zhang; Gregory C Copley; James C Hower; Andrew J Morris; Madan K Kharel; Jon S Thorson
Journal:  J Nat Prod       Date:  2013-08-14       Impact factor: 4.050

4.  Total synthesis of griseusins and elucidation of the griseusin mechanism of action.

Authors:  Yinan Zhang; Qing Ye; Larissa V Ponomareva; Yanan Cao; Yang Liu; Zheng Cui; Steven G Van Lanen; S Randal Voss; Qing-Bai She; Jon S Thorson
Journal:  Chem Sci       Date:  2019-06-27       Impact factor: 9.825
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.